ISAL 2019 | Prevention, detection and treatment of AML relapse after allo-SCT

Name: Prevention, detection and treatment of AML relapse after allo-SCT
Uploaded: 2019-03-14T11:56:11.000Z
Duration: 1 min 13 s
Description: Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses the prevention, detection and treatment of the acute myeloid leukemia (AML) relapse after allogeneic stem cell transplantation. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Thomas Schröder • 14 Mar 2019

ISAL 2019

Acute Myeloid Leukemia Leukemia

Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses the prevention, detection and treatment of the acute myeloid leukemia (AML) relapse after allogeneic stem cell transplantation. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.